These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34756682)

  • 1. When CFSPID becomes CF.
    Ginsburg D; Wee CP; Reyes MC; Brewington JJ; Salinas DB
    J Cyst Fibros; 2022 Jan; 21(1):e23-e27. PubMed ID: 34756682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
    Salinas DB; Ginsburg DK; Wee CP; Saeed MM; Brewington JJ
    Pediatr Pulmonol; 2023 Apr; 58(4):1074-1084. PubMed ID: 36582049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
    Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
    J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.
    Fevola C; Dolce D; Tosco A; Padoan R; Daccò V; Claut L; Schgor T; Sepe A; Timpano S; Fabrizzi B; Piccinini P; Taccetti G; Bonomi P; Terlizzi V
    Eur J Pediatr; 2024 Feb; 183(2):929-938. PubMed ID: 38054992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
    Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
    J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.
    Gonska T; Keenan K; Au J; Dupuis A; Chilvers MA; Burgess C; Bjornson C; Fairservice L; Brusky J; Kherani T; Jober A; Kosteniuk L; Price A; Itterman J; Morgan L; Mateos-Corral D; Hughes D; Donnelly C; Smith MJ; Iqbal S; Arpin J; Reisman J; Hammel J; van Wylick R; Derynck M; Henderson N; Solomon M; Ratjen F
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
    Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
    Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different management approaches and outcome for infants with an inconclusive diagnosis following newborn screening for cystic fibrosis (CRMS/CFSPID) and Pseudomonas aeruginosa isolation.
    Dolce D; Claut L; Colombo C; Tosco A; Castaldo A; Padoan R; Timpano S; Fabrizzi B; Bonomi P; Taccetti G; Terlizzi V
    J Cyst Fibros; 2023 Jan; 22(1):73-78. PubMed ID: 35869019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
    Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
    BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review.
    Terlizzi V; Manti S; D'Amico F; Parisi GF; Chiappini E; Padoan R
    Paediatr Respir Rev; 2024 Sep; 51():46-55. PubMed ID: 38309973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of the sweat test in children with Cystic Fibrosis previously CRMS/CFSPID: A retrospective monocenter experience.
    Terlizzi V; Dolce D
    J Cyst Fibros; 2023 May; 22(3):496-498. PubMed ID: 37117083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
    J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results.
    Ginsburg DK; Salinas DB; Cosanella TM; Wee CP; Saeed MM; Keens TG; Gold JI
    J Cyst Fibros; 2023 May; 22(3):420-426. PubMed ID: 36528525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosis.
    Terlizzi V; Claut L; Colombo C; Tosco A; Castaldo A; Fabrizzi B; Lucarelli M; Cimino G; Carducci C; Dolce D; Biffi A; Bonomi P; Timpano S; Padoan R
    Pediatr Pulmonol; 2021 Dec; 56(12):3785-3791. PubMed ID: 34549893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.
    Kay DM; Sadeghi H; Kier C; Berdella M; DeCelie-Germana JK; Soultan ZN; Goetz DM; Caggana M; Fortner CN; Giusti R; Kaslovsky R; Stevens C; Voter K; Welter JJ; ; Langfelder-Schwind E
    Pediatr Pulmonol; 2024 Jul; 59(7):1952-1961. PubMed ID: 38695616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial assessments.
    Manzoor J; Hughes DA
    Paediatr Respir Rev; 2023 Sep; 47():19-22. PubMed ID: 37365112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is cystic fibrosis screen positive inconclusive diagnosis? And what is it not?
    Devoy E; Hughes D; Alharbi AF; Francis J; Davies JC
    Arch Dis Child Educ Pract Ed; 2024 Sep; 109(5):237-241. PubMed ID: 38453427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.